Neuroscience
Alzheimer's Disease
100%
Cholinergic
67%
Synapse
62%
Hippocampus
56%
Apolipoprotein A
56%
Presenilin 1
56%
Long-Term Depression
56%
Simvastatin
56%
Cerebral Amyloid Angiopathy
56%
Long-Term Potentiation
56%
Extracellular Signal-Regulated Kinases
56%
Physostigmine
56%
Acetylcholinesterase Inhibitor
56%
Glycogen Synthase Kinase 3
56%
Amyloid Precursor Protein
56%
Cholinergic Receptor
42%
Statin
37%
Heat Shock Protein 70
37%
Carbachol
36%
Acetylcholinesterase
33%
Blood Plasma
31%
In Vivo
28%
High-Density Lipoprotein
24%
Imaging Technique
14%
Parkinson's Disease
14%
Protein Kinase B
12%
High Density Lipoprotein Cholesterol
12%
Parasympathetic Innervation
11%
Glutamic Acid
11%
Synaptic Plasticity
11%
Receptor
11%
Anabolism
6%
Chemokine
6%
Cell Membrane Potential
6%
Brain Slice
6%
In Vitro
6%
Synapsin I
6%
Traumatic Brain Injury
6%
Neurotrauma
6%
Water Maze
6%
Anti-Inflammatory
6%
Amyloid Protein
6%
Cerebrovascular Accident
6%
Pharmacology, Toxicology and Pharmaceutical Science
C57BL 6 Mouse
56%
Physostigmine
56%
Cholinesterase Inhibitor
56%
Simvastatin
56%
Nanoplastics
56%
Acetylcholinesterase
33%
Alzheimer's Disease
29%
Hydroxymethylglutaryl Coenzyme A Reductase Inhibitor
24%
Carbachol
22%
Cholinergic Receptor Stimulating Agent
22%
Protein Kinase B
12%
Transgenic Mouse
12%
Statin (Protein)
12%
Glutamic Acid
11%
Receptor
11%
Combination Therapy
11%
Artemia
11%
Traumatic Brain Injury
6%
Prevalence
6%
Oxidoreductase
6%
Prospective Study
6%
Cerebrovascular Accident
6%
Gliosis
5%
Glial Fibrillary Acidic Protein
5%
Soil Water
5%
Biochemistry, Genetics and Molecular Biology
Long Term Potentiation
56%
Simvastatin
56%
Farnesyl Pyrophosphate
56%
Protein Kinase B
26%
Transgenic Mouse
14%
C57BL 6 Mouse
7%
Anabolism
7%
Oxidoreductase
7%
Reductase
7%
Geranylgeranyl Pyrophosphate
7%
Isoprenylation
7%
Geranylgeranylation
7%
Pleiotropy
7%
Farnesyltransferase
7%
Mouse Model
7%
Amyloid Beta
7%
Wild Type
7%
Phosphoinositide 3-Kinase
7%
Hypercholesterolemia
7%
Competitive Inhibition
7%
